📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Vedolizumab use and the associations between a4ß7 expression and HIV reservoir in the gut during treated primary HIV infection. (2019)

First Author: Thornhill JP

Attributed to: MICA: ERADICATE HIV-1: TARGETING THE HIV-1 RESERVOIR WITH NEW IMMUNOTHERAPEUTIC STRATEGIES funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1097/qad.0000000000002344

PubMed Identifier: 31688047

Publication URI: http://europepmc.org/abstract/MED/31688047

Type: Journal Article/Review

Volume: 33

Parent Publication: AIDS (London, England)

Issue: 14

ISSN: 0269-9370